Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
58M
-
Shares change
-
+2.95M
-
Total reported value, excl. options
-
$9.24B
-
Value change
-
+$506M
-
Put/Call ratio
-
1.45
-
Number of buys
-
96
-
Number of sells
-
-79
-
Price
-
$159.39
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2021
214 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q3 2021.
Ascendis Pharma A/S - ADR (ASND) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58M shares
.
Largest 10 shareholders include Artisan Partners Limited Partnership (7.78M shares), RA CAPITAL MANAGEMENT, L.P. (7.39M shares), FMR LLC (5.39M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.84M shares), BAKER BROS. ADVISORS LP (4.54M shares), WELLINGTON MANAGEMENT GROUP LLP (3.95M shares), JANUS HENDERSON GROUP PLC (3.25M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.11M shares), Avoro Capital Advisors LLC (1.98M shares), and EVENTIDE ASSET MANAGEMENT, LLC (1.75M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.